FDMT 4D Molecular Therapeutics Inc

Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. 4D Molecular Therapeutics Inc market cap is $567.77M.

52 week high is the highest price of a stock in the past 52 weeks, or one year. 4D Molecular Therapeutics Inc 52 week high is $26.49 as of December 03, 2023.

52 week low is the lowest price of a stock in the past 52 weeks, or one year. 4D Molecular Therapeutics Inc 52 week low is $9.44 as of December 03, 2023.

4D Molecular Therapeutics Inc stock price today is $13.28.

4D Molecular Therapeutics Inc stock price yesterday was $12.72.

The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. 4D Molecular Therapeutics Inc’s P/E ratio is -4.86.

The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. 4D Molecular Therapeutics Inc P/B ratio is 1.7208.

EBITDA is a widely used measure of corporate profitability. It stands for Earnings before Interest, Taxes, Depreciation, and Amortization. It attempts to reflect the cash profit generated by a company’s operations. 4D Molecular Therapeutics Inc's EBITDA is -2.35.

The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. 4D Molecular Therapeutics Inc 50-day moving average is $11.50.

4D Molecular Therapeutics Inc has 140 employees.